top of page




Supported projects
Onconex-Remunity Therapeutics
Develops next-generation immunotherapies for the treatment of cancer. Its clinical platform is based on innovative approaches aimed at boosting the anti-tumour immune response and overcoming resistance to current treatments.
PSCC's entrance
Décembre 2025
Localization
FR - Île-de-France
Modality
Immunotherapy
Development status
Biotech - Phase 1/2a
Lauréat (s)
bottom of page